146 related articles for article (PubMed ID: 12468325)
1. Surgical stage I endometrial cancer: predictors of distant failure and death.
Mariani A; Webb MJ; Keeney GL; Lesnick TG; Podratz KC
Gynecol Oncol; 2002 Dec; 87(3):274-80. PubMed ID: 12468325
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer: predictors of peritoneal failure.
Mariani A; Webb MJ; Keeney GL; Aletti G; Podratz KC
Gynecol Oncol; 2003 May; 89(2):236-42. PubMed ID: 12713986
[TBL] [Abstract][Full Text] [Related]
3. Assessment of prognostic factors in stage IIIA endometrial cancer.
Mariani A; Webb MJ; Keeney GL; Aletti G; Podratz KC
Gynecol Oncol; 2002 Jul; 86(1):38-44. PubMed ID: 12079298
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes and patterns of failure in women with stage IIIC
Lee JK; Mahan M; Hanna RK; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
[TBL] [Abstract][Full Text] [Related]
5. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.
Kokcu A; Kurtoglu E; Celik H; Kefeli M; Tosun M; Onal M
Asian Pac J Cancer Prev; 2015; 16(13):5331-5. PubMed ID: 26225674
[TBL] [Abstract][Full Text] [Related]
6. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
Mariani A; Webb MJ; Keeney GL; Calori G; Podratz KC
Gynecol Oncol; 2001 Oct; 83(1):72-80. PubMed ID: 11585416
[TBL] [Abstract][Full Text] [Related]
7. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
8. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
9. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
[TBL] [Abstract][Full Text] [Related]
10. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
11. Patterns of failures in endometrial cancer: clinicopathological variables predictive of the risk of local, distant and retroperitoneal failure.
Gadducci A; Cosio S; Fabrini MG; Fanucchi A; Barsotti C; Cristofani R; Greco C; Genazzani AR
Anticancer Res; 2011 Oct; 31(10):3483-8. PubMed ID: 21965765
[TBL] [Abstract][Full Text] [Related]
12. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
13. Molecular and histopathologic predictors of distant failure in endometrial cancer.
Mariani A; Sebo TJ; Webb MJ; Riehle D; Katzmann JA; Keeney GL; Roche PC; Lesnick TG; Podratz KC
Cancer Detect Prev; 2003; 27(6):434-41. PubMed ID: 14642551
[TBL] [Abstract][Full Text] [Related]
14. Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano JM
Am J Clin Oncol; 2018 Apr; 41(4):371-378. PubMed ID: 26950465
[TBL] [Abstract][Full Text] [Related]
15. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
16. Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy.
Kumar VJ; Nin CY; Kuei LY; Tan KH; Yeo R; Lam PY
Int J Gynecol Cancer; 2010 May; 20(4):564-9. PubMed ID: 20686374
[TBL] [Abstract][Full Text] [Related]
17. Analysis of FIGO Stage IIIc endometrial cancer patients.
McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R
Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
[TBL] [Abstract][Full Text] [Related]
18. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial.
Eltabbakh GH; Piver MS; Hempling RE; Shin KH
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):373-80. PubMed ID: 9226326
[TBL] [Abstract][Full Text] [Related]
19. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular space invasion and the treatment of stage I endometrioid endometrial cancer.
van der Putten LJ; Geels YP; Ezendam NP; van der Putten HW; Snijders MP; van de Poll-Franse LV; Pijnenborg JM
Int J Gynecol Cancer; 2015 Jan; 25(1):75-80. PubMed ID: 25356534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]